Paper Details

  1. Home
  2. Paper Details

Patient preferences among third agent HIV medications: a US and German perspective.

Author: BeusterienK M, DavisE A, DziekanK, FloodE, FloodR, SchraderS, ShearerA

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study assessed patient preferences for third-agent HIV medications. Drug resistance, lipodystrophy risk, gastrointestinal side effects, and regimen convenience were the most important attributes influencing preferences. Fosamprenavir/ritonavir was the most preferred medication profile.
Paper Details　
Original Abstract of the Article :
The objective is to assess patient preferences for attributes associated with third agent HIV medications, including fosamprenavir/ritonavir (FPVr), fosamprenavir (FPV), lopinavir/ritonavir (LPVr), atazanavir (ATZ), and efavirenz (EFV). Subjects with HIV were recruited in the US and Germany to compl...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/09540120701294278

データ提供：米国国立医学図書館（NLM）

Navigating the Sands of HIV Treatment: Patient Preferences for Third-Agent Medications

In the [field of HIV treatment], finding the right combination of medications can be like navigating a complex desert landscape. This study delves into the preferences of [HIV patients] in the [US and Germany] when it comes to [third-agent HIV medications]. The authors employed a [computerized adaptive conjoint survey] to uncover what matters most to patients, revealing the hidden preferences buried within their individual journeys.

The Importance of Patient Voice in the Desert of HIV

The study found that [developing drug resistance, lipodystrophy risk, gastrointestinal side effects, and regimen convenience] were the most influential factors impacting patients’ preferences. This research emphasizes the importance of [patient-centered care], where the voices of those navigating the desert of HIV treatment are heard and respected.

Finding the Right Oasis: A Collaborative Journey

The results underscore the need for [open communication between patients and healthcare providers]. By understanding the unique preferences of each patient, clinicians can create a personalized treatment plan that feels like finding a refreshing oasis in the vastness of their medical journey.

Dr. Camel's Conclusion

This study underscores the importance of considering patient preferences in HIV treatment. By taking the time to understand their individual needs and concerns, healthcare providers can navigate the desert of HIV treatment in a way that is both effective and empowering. Together, we can find oases of hope and well-being for those living with this challenging condition.

Date :
  1. Date Completed 2008-02-27
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

17851994

DOI: Digital Object Identifier

10.1080/09540120701294278

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.